STOCK TITAN

Wearable Devices to Unveil GenAI-Powered Intent-Based Interface Platform and Next-Gen Mudra Pro Flagship at AWE 2026

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

Wearable Devices (Nasdaq: WLDS) will present its neural input ecosystem at AWE 2026 in Long Beach, June 15–18, 2026. The company will showcase Mudra Pro, the next-gen enterprise hardware platform, the GenAI-powered Mudra Studio software, and Mudra Link live neural input demos for AI, XR and robotics.

Founder and President Guy Wagner will deliver a featured talk on brain-computer interfaces on June 18, 2026, at 1:40 p.m. PT.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • None.

Negative

  • None.

News Market Reaction – WLDS

+26.52% 32.3x vol
54 alerts
+26.52% News Effect
+72.5% Peak Tracked
-8.3% Trough Tracked
+$2M Valuation Impact
$9.43M Market Cap
32.3x Rel. Volume

On the day this news was published, WLDS gained 26.52%, reflecting a significant positive market reaction. Argus tracked a peak move of +72.5% during that session. Argus tracked a trough of -8.3% from its starting point during tracking. Our momentum scanner triggered 54 alerts that day, indicating high trading interest and price volatility. This price movement added approximately $2M to the company's valuation, bringing the market cap to $9.43M at that time. Trading volume was exceptionally heavy at 32.3x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Registered shares (F-3): 5,082,873 Ordinary Shares New Warrant exercise price: $1.51 Potential warrant proceeds: $7.7 million +5 more
8 metrics
Registered shares (F-3) 5,082,873 Ordinary Shares F-3 resale registration for New Warrants
New Warrant exercise price $1.51 Exercise price per share for 5,082,873 New Warrants
Potential warrant proceeds $7.7 million Cash to company if all New Warrants exercised for cash
Shares outstanding 6,546,510 shares Outstanding as of May 11, 2026 (F-3 filing)
Pro forma shares 11,629,383 shares Assuming full cash exercise of all New Warrants
Registered warrant shares 2,904,500 Ordinary Shares POS AM resale registration tied to prior private placement warrants
IPO warrant proceeds $18.6 million Potential cash if all registered warrants exercised for cash
Accumulated deficit $37.2 million As of December 31, 2025 (Form 20-F)

Peers on Argus

WLDS was down 2.63% with light volume while momentum peers were mixed: VUZI up 8...
1 Up 1 Down

WLDS was down 2.63% with light volume while momentum peers were mixed: VUZI up 8.97% and WTO down 6.31%. Broader Consumer Electronics peers also showed both gains and losses, indicating the move appeared stock-specific rather than a coordinated sector rotation.

Historical Context

5 past events · Latest: Jun 04 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Jun 04 Pre-order launch Positive +6.1% Opened early pre-orders for Mudra Pro targeting AI and XR enterprise users.
May 19 AR partnership Positive -5.2% Announced Meta-Bounds collaboration bringing Mudra neural control to AR glasses.
May 13 Product announcement Positive +1.9% Introduced Mudra Pro next-generation neural sensing platform for AI and XR.
Apr 24 Patent allowance Positive +17.0% Received USPTO Notice of Allowance for biometric authentication in gesture interface.
Apr 20 Warrant financing Negative -13.9% Announced warrant inducement transaction for $5.0M gross proceeds and new warrants.
Pattern Detected

News reactions have mostly aligned with sentiment, with one notable divergence on a positive AR collaboration update.

Recent Company History

Over the last few months, WLDS has focused on commercializing its Mudra neural-input platform. Product launches and pre-orders for Mudra Pro and related AI/XR tools on May 13 and June 4 saw modest positive reactions. A patent Notice of Allowance on April 24 coincided with a stronger 17% gain. By contrast, an AR collaboration update on May 19 drew a negative reaction, and an April warrant inducement for $5.0 million was also sold off.

Regulatory & Risk Context

Active S-3 Shelf · $7.7 million · Short Interest: 3.03%
Shelf Active
Short Interest
3.03% of shares outstanding
as of 2026-05-29 Days to cover: 1
Active S-3 Shelf Registration 2026-05-12
$7.7 million registered capacity

An effective F-3 filed on 2026-05-12 registers 5,082,873 Ordinary Shares underlying new warrants at $1.51. The company would receive up to $7.7 million in cash only if these warrants are exercised in full for cash; resales themselves do not provide proceeds.

Market Pulse Summary

The stock surged +26.5% in the session following this news. A strong positive reaction aligns with p...
Analysis

The stock surged +26.5% in the session following this news. A strong positive reaction aligns with prior responses to technology milestones, such as the 17% move on the patent allowance and gains on earlier Mudra Pro news. However, investors previously sold into financing events like the warrant inducement. An effective shelf for 5,082,873 warrant shares and potential dilution to 11,629,383 shares could become an overhang if enthusiasm fades.

Key Terms

electromyography, emg, inertial measurement unit, photoplethysmography, +1 more
5 terms
electromyography medical
"featuring built-in electromyography (EMG), inertial measurement unit (IMU), and"
Electromyography (EMG) is a medical test that records the tiny electrical signals muscles make when they contract, using sensors placed on or in the muscle—think of it as checking the wiring and signals between nerves and muscles. Investors care because EMG is a key tool for diagnosing neuromuscular conditions and evaluating treatments or devices; clear EMG results can influence clinical adoption, regulatory decisions and the commercial prospects of related healthcare products.
emg medical
"featuring built-in electromyography (EMG), inertial measurement unit (IMU), and"
Electromyography (EMG) is a diagnostic test that measures the tiny electrical signals produced by muscles when they contract, using sensors placed on the skin or small needles inserted into the muscle. For investors, EMG results matter when they relate to medical devices, drugs, or therapies because clear improvements or safety signals can indicate clinical benefit and drive regulatory approval, market adoption, and potential revenue—similar to an electrician testing wiring to confirm a building is safe and functional.
inertial measurement unit technical
"featuring built-in electromyography (EMG), inertial measurement unit (IMU), and"
An inertial measurement unit (IMU) is a small electronic device that uses internal sensors to track an object’s movement, orientation and rotation—like the motion sensors in a smartphone that know if you’ve tilted or moved it. Investors care because IMUs are core components in products from drones and smartphones to cars and industrial machines; their performance, cost and supply affect a manufacturer’s product quality, market competitiveness and potential revenue growth.
photoplethysmography medical
"and photoplethysmography (PPG) sensors to deliver advanced user intent"
Photoplethysmography is an optical method that uses light shining into the skin to detect tiny changes in blood volume with each heartbeat, producing simple waveforms that indicate pulse, blood flow and sometimes blood oxygen levels. Investors care because it is a core sensing technology for consumer wearables and medical devices — its accuracy, cost, regulatory acceptance and data privacy implications affect product adoption, recurring revenues and valuation of companies using it.
brain-computer interface medical
"titled “How BCI is Removing the Friction from AR and AI Interaction”."
A brain-computer interface is a device or system that reads electrical signals from the brain and translates them into commands a computer or machine can understand, like a translator turning thoughts into actions. For investors, it matters because these technologies can create new markets in healthcare, assistive devices and consumer electronics, but they also carry high development costs, regulatory hurdles and uncertain adoption timelines that affect potential returns and risk.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

The Company will showcase its hardware-agnostic neural input ecosystem including Mudra Pro and Mudra Studio, and live neural input demonstrations for AI, XR and robotics 

YOKNEAM ILLIT, ISRAEL, June 15, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (Wearable Devices or the Company), a pioneer in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced its comprehensive lineup for the Augmented World Expo 2026 (AWE 2026). The premier industry conference is set to take place June 15 to 18, 2026, in Long Beach, California, At Booth 648 on the expo floor and in meeting room Hall 201A.

As spatial computing and AI agents converge, Wearable Devices is positioning its proprietary neural-input technology as a leading solution for intent-based interfaces. Unlike legacy camera-based motion tracking, the technology decodes neural impulses before physical movement occurs, offering an ultra-low latency, private, and socially acceptable control layer for the future of computing.

Guy Wagner, the Company’s Founder, President, Chief Scientist, and Director, will deliver a featured presentation titled “How BCI is Removing the Friction from AR and AI Interaction”. The session will discuss how brain-computer interface (BCI) technologies and neural input can reduce interaction barriers for augmented reality (“AR”), AI and spatial computing. It will also highlight more natural, private and intuitive ways to control smart glasses and connected devices. The presentation will be held on Thursday, June 18, 2026, at 1:40 p.m. PT.

Wearable Devices will demonstrate the commercial readiness of its full-stack ecosystem across two distinct footprints designed to accelerate original equipment manufacturer (“OEM”) partnerships and enterprise sales. At Booth 648 on the expo floor, attendees can try Mudra Link by controlling applications in precision pointer mode or directional pad mode. In these demos, Mudra Link works as an alternative to camera-based gesture tracking or handheld devices.

In Hall 201A, the Company will host exclusive Innovation Sprint sessions, B2B executive meetings, media interviews, and technical evaluations intended to secure upstream licensing and enterprise pilots. These activities include the commercial launch of Mudra Pro, the next-generation enterprise hardware platform featuring built-in electromyography (EMG), inertial measurement unit (IMU), and photoplethysmography (PPG) sensors to deliver advanced user intent recognition. The Company will also demonstrate Mudra Studio, a software platform designed to leverage generative AI that allows developers to create, test, and deploy gesture-based neural input experiences using text prompts. It provides the AI interaction layer to scale Mudra across third-party devices.

Invite-only 45-minute Innovation Sprint sessions will allow corporate innovation teams, OEMs, enterprises, and developers to bring one interaction challenge and work with the Company’s AI and data experts to build a rapid software prototype based on their own needs. The suite will also host Mudra Ultimate guided discovery sessions with strategic enterprise prospects to explore product fit, workflow needs, and potential collaboration paths.

“Neural input can become a practical control layer for AI and extended reality (“XR”) devices, just as controllers and camera-based gestures have shaped today’s XR interfaces”, said Guy Wagner, Founder, President and Chief Scientist of Wearable Devices. “Mudra is designed to let users express intent naturally. This is especially important as smart glasses with spatial awareness become the primary interface with AI agents and platforms.”

Enterprise teams, OEMs, and media partners can request private briefings, review the Mudra Studio SDK capabilities, or apply for remaining Innovation Sprint slots at https://wlds.fillout.com/awe-innovationsprint.

About Wearable Devices

Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its AI-powered neural input touchless technology. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company’s consumer products - the Mudra Band and Mudra Link - are defining the neural input category both for wrist-worn devices and for brain-computer interfaces. These products enable touch-free, intuitive control of digital devices using gestures across multiple operating systems.
Operating through a dual-channel model of direct-to-consumer sales and enterprise licensing and collaborations, Wearable Devices empowers consumers with stylish, functional wearables for enhanced experiences in gaming, productivity, and XR. In the business sector, the Company provides enterprise partners with advanced input solutions for immersive and interactive environments, from augmented reality/virtual reality/XR to smart environments. By setting the standard for neural input in the XR ecosystem, Wearable Devices is shaping the future of seamless, natural user experiences across some of the world’s fastest-growing tech markets. The newly launched ai6 Labs ecosystem accelerates this vision by integrating research, products, and AI breakthroughs. Wearable Devices’ ordinary shares and warrants trade on the Nasdaq Capital Market under the symbols “WLDS” and “WLDSW,” respectively.

Forward-Looking Statements Disclaimer

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, we are using forward-looking statements when we discuss our participation in AWE 2026, the products, technologies, presentations and demonstrations that we plan to showcase at the event, the anticipated capabilities and benefits of our neural-input technology and products, the planned introduction of Mudra Pro, the functionality and potential applications of Mudra Studio, our efforts to engage with OEMs, enterprise customers, developers and other industry participants, and potential licensing opportunities, enterprise pilot programs, collaborations and other commercial opportunities that may result from such activities .  All statements other than statements of historical facts included in this press release regarding our strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the trading of our ordinary shares or warrants and the development of a liquid trading market; our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our annual report on Form 20-F for the year ended December 31, 2025, filed on March 12, 2026 and our other filings with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations Contact:

Michal Efraty

IR@wearabledevices.co.il


FAQ

What will Wearable Devices (NASDAQ: WLDS) showcase at AWE 2026?

Wearable Devices will showcase its hardware-agnostic neural input ecosystem, including Mudra Pro, Mudra Studio, and Mudra Link demos. According to Wearable Devices, these solutions target AI, XR and robotics with intent-based, ultra-low-latency control using decoded neural impulses instead of legacy camera-based tracking.

When and where is Wearable Devices presenting at AWE 2026?

Wearable Devices will appear at AWE 2026 in Long Beach, California, from June 15–18, 2026. According to Wearable Devices, its featured brain-computer interface presentation by Guy Wagner is scheduled for Thursday, June 18, 2026, at 1:40 p.m. PT.

What is Mudra Pro, unveiled by Wearable Devices (WLDS) at AWE 2026?

Mudra Pro is Wearable Devices’ next-generation enterprise hardware platform with built-in EMG, IMU and PPG sensors. According to Wearable Devices, it aims to deliver advanced user intent recognition as part of a full-stack neural input ecosystem for AI, XR and enterprise applications.

How does the Mudra Studio GenAI platform from WLDS work for developers?

Mudra Studio is a software platform that uses generative AI to build neural input experiences via text prompts. According to Wearable Devices, it lets developers create, test and deploy gesture-based interactions and provides the AI layer to scale Mudra across third-party devices.

What are Wearable Devices’ Innovation Sprint sessions at AWE 2026?

Innovation Sprint sessions are invite-only 45-minute workshops for corporate innovation teams, OEMs, enterprises and developers. According to Wearable Devices, participants bring one interaction challenge and collaborate with the company’s AI and data experts to rapidly prototype a tailored neural input software solution.

Where can investors find Wearable Devices at AWE 2026?

Investors and attendees can visit Wearable Devices at Booth 648 on the AWE 2026 expo floor and in Hall 201A. According to Wearable Devices, Hall 201A will host Innovation Sprints, executive meetings, media interviews and technical evaluations for potential OEM and enterprise collaborations.